Cameron Gray
Director at Cue Biopharma, Inc. (CUE)
Cameron Gray has filed 3 insider reports with the SEC since February 2021, as director at Cue Biopharma, Inc. (CUE). The latest filing, on June 16, 2022, reports shares withheld for taxes or exercise price and exercise of an in-the-money derivative at Cue Biopharma, Inc. (CUE).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Cameron Gray is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 687,049 | $4.76 | Jun 16, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 14, 2022CUESEC Form 4: Gray Cameron exercised 61,111 in-the-money shares at a strike of $2.70 and covered exercise/tax liability with 51,562 shares, increasing direct ownership by 1% to 687,049 unitsForm 4Shares withheld for taxes or exercise priceExercise of an in-the-money derivative
- Jan 3, 2022CUESEC Form 4 filed by Gray CameronForm 4Grant or award
- Dec 2, 2020CUESEC Form 5: Cameron Gray gifted 596,200 units of Common Stock and received a gift of 596,200 units of Common Stock, decreasing ownership by 88% to 81,300 unitsForm 5Gift
Compare Cameron Gray with
- Cameron Gray vs Pasha Sarraf1 shared
- Cameron Gray vs Pamela Garzone1 shared
- Cameron Gray vs Sumita Ray1 shared
- Cameron Gray vs Michael Vincent Meluzio1 shared
- Cameron Gray vs Shao-Lee Lin1 shared
- Cameron Gray vs James M Ahlers1 shared
Other insiders at the same companies
- Pasha SarrafCUE
- Pamela GarzoneCUE
- Sumita RayCUE
- Michael Vincent MeluzioCUE
- Shao-Lee LinCUE
- James M AhlersCUE
- Dominique Christian BorieCUE
- Daniel A. CamardoCUE
- Viola Mong MeehanCUE
- Lucinda WarrenCUE
- Colin SandercockCUE
- Daniel G. BakerCUE
- Jill Marie BroadfootCUE
- Peter A KienerCUE
- Frank MorichCUE
- Patrick VerheyenCUE
Questions about Cameron Gray
- What is Cameron Gray's role at Cue Biopharma, Inc.?
- Cameron Gray reports to the SEC as director at Cue Biopharma, Inc. (CUE), according to the latest filing on June 16, 2022.
- How many shares does Cameron Gray own?
- After the latest filing that states it, Cameron Gray directly owned 687,049 shares of Cue Biopharma, Inc. (CUE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Cameron Gray bought or sold stock recently?
- No open-market purchases or sales by Cameron Gray are on file. The filings report shares withheld for taxes or exercise price, exercise of an in-the-money derivative, grant or award and gift.
- How do I get alerts when Cameron Gray files?
- Follow Cameron Gray on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Cameron Gray (SEC CIK 0001590583). Totals count each trade once, skipping amendments whose original is on file, from Feb 1, 2021 on. View on SEC EDGAR